Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis

Volume 48, no. 10, p. 4063-4066, 2004. Page 4064, column 2: The last sentence should read “AmB and POS (POS was used at 5, 25, or 100 mg/kg) were equivalent in reducing CFU from either brain or kidneys.”

Page 4065, column 1: The second sentence of the first full paragraph should read “CAS, the first of the echinocandins to be licensed, for use as salvage therapy in invasive aspergillosis, inhibits the synthesis of 1,3-β-d-glucan, a component of the fungal cell wall (10, 36).”